| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910831885003321 |
|
|
Autore |
Gibbon Sahra |
|
|
Titolo |
Breast cancer gene research and medical practices : transnational perspectives in the time of BRCA / / edited by Sahra Gibbon. [et al.] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Taylor & Francis, 2014 |
|
Milton Park, Abingdon, Oxon : , : Routledge, , 2014 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-135-92552-6 |
0-203-38551-9 |
1-135-92545-3 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (248 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
|
|
Soggetti |
|
Breast - Cancer - Genetic aspects |
BRCA genes |
Tumor markers |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Title; Copyright; Contents; List of contributors; Foreword; Preface; Introduction; SECTION I Practices of population, politics and history in the production of BRCA; 1 The presence of the past: 'Ashkenazi BRCA mutations' and transnational differences in categories of 'race' and 'ethnicity': the German case; 2 Mapping Jewish identities: migratory histories and the transnational re-framing of the 'Ashkenazi BRCA mutations' in the UK and Brazil; 3 Genetics to the people: BRCA as public health and the dissemination of cancer risk knowledge |
Middleword I: Historicizing biomedicine: toward a history of the present of BRCASECTION II Risk, personhood and subjectivity; 4 Situating breast cancer risk in urban India: gender, temporality and social change; 5 Gender trouble? Queering the medical normativity of BRCA femininities; 6 It takes a particular world to produce and enact BRCA testing: the US had it, Italy had another; Middleword II: Pushing the boundaries; SECTION III Shifting terrains of BRCA knowledge and practices; 7 'Empowerment' and the rendering of biocapital in direct-to-consumer |
|
|
|
|
|
|
|
|
|
|
|
personal genomics |
8 The BRCA patent controversies: an international review of patent disputes9 From BRCA to BRCAness: tales of translational research; 10 Ethical analysis of PGD for BRCA: attending to more than risks and benefits; Afterword: Studying BRCA performativity: re-calibrations by and of the social sciences; Index |
|
|
|
|
|
|
Sommario/riassunto |
|
The discovery of the two inherited susceptibility genes BRCA1 and BRCA2 in the mid-1990s created the possibility of predictive genetic testing and led to the establishment of specific medical programmes for those at high risk of developing breast cancer in the UK, US and Europe. In the intervening fifteen years, the medical institutionalisation of these knowledge-practices and accompanying medical techniques for assessing and managing risk have advanced at a rapid pace across multiple national and transnational arenas, whilst also themselves constituting a highly mobile and shifting terrain |
|
|
|
|
|
|
|
| |